Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
You may also like
Bold Ventures Announces Further Increase of Non-brokered Private Placement
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce that the ...
Red Metal Resources Provides Update on Results of Mapping Program on Its Carrizal IOCG Property
Red Metal Resources Ltd. (CSE: RMES) (OTC Pink: RMESF) (FSE: I660) (‘Red Metal’ or the ...